Burden of illness among commercially insured patients with Alzheimer's disease

Alzheimer's and Dementia

Volumn 3, Issue 3, 2007, Pages 204-210

  Joyce, Amie T ^a   Zhao, Yang ^b   Bowman, Lee ^b   Flynn, Jennifer A ^b   Carter, Chureen T ^a   Ollendorf, Daniel A ^a  

^a PharMetrics Inc   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Cost of illness; Direct service costs; Managed health care insurance plans; Medicare plus Choice; Prescription insurance

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHOLINESTERASE INHIBITOR; NEUROLEPTIC AGENT;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COST OF ILLNESS; DEMENTIA; DEMOGRAPHY; DRUG COST; FEMALE; FOLLOW UP; GENDER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 34249680308     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.04.373     Document Type: Article

References (22)

1. th ed. (2001), McGraw Hill, New York 2391-2398
2. Rice D.P., Fillit H.M., Max W., Knopman D.S., Lloyd J.R., and Duttagupta S. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. Am J Manag Care 7 (2001) 809-818
3. Statistics about Alzheimer's disease. Available at: http://www.alz.org/AboutAD/Statistics.htm. Alzheimer's Association, 2004. Accessed September 23, 2004.
4. Causes of Alzheimer's disease. Available at: http://www.alzheimers.org/causes.htm. Alzheimer's Disease Education and Referral Center, 2004. Accessed September 23, 2004.
5. Losing a million minds: confronting the tragedy of Alzheimer's disease and other dementias (1987), US Congress Office of Technology Assessment, U.S. Government Printing Office, Washington, DC
6. Rice D.P., Fox P.J., Max W., Webber P.A., Lindeman D.A., Hauck W.W., et al. The economic burden of Alzheimer's disease care. Health Affairs 12 (1993) 164-176
7. Medicare and Medicaid costs for people with Alzheimer's disease (2001), Alzheimer's Association, Washington, D.C
8. Heart disease burden: chronic disease notes and reports (2004), Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health, Atlanta
9. Diabetes Self Management Training Act of 2005. Available at: http://www.theorator.com/bills109/s626.html. Data referenced in bill presented to the US 109th Congress, 1st session, S. 626, March 15, 2005. Accessed: June 16, 2005.
10. 2001-2002 Alzheimer's disease progress report (2003), National Institutes of Health, Bethesda, MD Publication number 03-5333
11. Leon J., and Neumann P.J. The cost of Alzheimer's disease in managed care: a cross-sectional study. Am J Manag Care 5 (1999) 867-877
12. Gutterman E.M., Markowitz J.S., Lewis B., and Fillit H. Cost of Alzheimer's disease and related dementia in managed Medicare. J Am Geriatr Soc 47 (1999) 1065-1071
13. Fillit H., Hill J.W., and Futterman R. Health care utilization and costs of Alzheimer's disease: the role of comorbid conditions, disease stage, and pharmacotherapy. Fam Med 34 (2002) 528-535
14. Martin B.C., Ricci J.F., Kotzan J.A., Lang K., and Menzin J. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord 14 (2000) 151-159
15. Hill J.W., Futterman R., Duttagupta S., Mastey V., Lloyd J.R., and Fillit H. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology 58 (2002) 62-70
16. Richards K.M., Shepherd M.D., Crimson M.L., Snyder E.H., and Jermain D.M. Medical services utilization and charge comparisons between elderly patients with and without Alzheimer's disease in a managed care organization. Clin Ther 22 (2000) 775-791
17. Menzin J., Lang K., Friedman M., Neumann P., and Cummings J.L. The economic cost of Alzheimer's disease and related dementias to the California Medicaid Program ("Medi-Cal") in 1995. Am J Geriatr Psychiatry 7 (1999) 300-308
18. Rigaud A.S., Fagnani F., Bayle C., Latour F., Traykov L., and Forette F. Patients with Alzheimer's disease living at home in France: costs and consequences of the disease. J Geriatr Psychiatry Neurol 16 (2003) 140-145
19. Beeri M.S., Werner P., Adar Z., Davidson M., and Noy S. Economic cost of Alzheimer disease in Israel. Alzheimer Dis Assoc Disord 16 (2002) 73-80
20. Atance Martinez J.C., Yusta Izquierdo A., and Grupeli Gardel B.E. Costs study in Alzheimer's disease. Rev Clin Esp 204 (2004) 64-69
21. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40 (1987) 373-383
22. McCullagh P., and Nelder J.A. Generalized linear models (1989), Chapman and Hall, London